论文部分内容阅读
为了进一步提供药物应用的安全性信息,上市后的监测工作是必要的.香港中文大学临床药理科于1986年10月率先在该地区开始施行药物不良反应(ADRs)监测计划(下称计划),并逐步向该地区推广.计划规定医院医生和开业医生均应上报药物应用中发生的ADRs,甚至居民也可以利用信函上报.除了按具体的报告形式填表上报外,对紧要问题还可以利用电话上报.香港中文大学所属医院的临床药理科于1988年1月在该院某些有关科室设立了药品和毒物信息箱.该科于1989年12月以来还开展了毒理学、药物治疗和ADRs等方面的全天侯24小时的信息服务.香港两份医学杂志——《香港医学会杂志》(Journal of the Hong Kong Medical As-sociation)和《香港开业医生》(The Hong KongPractitioner)——的编辑部可代收ADRs报告.两份杂志还不定期地将上报的ADRs资料整理成册,免费分发给全香港的所有医生.有关报告的统一标准定期发表在《香港医
In order to further provide safety information on drug use, post-marketing monitoring is necessary. The Clinical Pharmacology Section of the Chinese University of Hong Kong took the lead in implementing the ADRs monitoring program (the scheme) in the area in October 1986, And gradually promote to the area.The plan stipulates that doctors and doctors should report the occurrence of ADRs in drug applications, and even residents can also use the letter reported.In addition to fill in the form according to the specific report reporting, the critical issues can also use the phone Reported that the Clinical Pharmacology Section of the Chinese University Hospital of Hong Kong established a Drug and Poison Information Box in certain relevant sections of the hospital in January 1988. The Section also conducted toxicology, pharmacotherapy and ADRs since December 1989 24 hours a day Information Services Two editorial magazines in Hong Kong - editors of the Journal of the Hong Kong Medical As-sociation and The Hong Kong Practitioner The department can collect ADRs reports. The two magazines also arrange the reported ADRs data from time to time to be distributed to all doctors in Hong Kong free of charge. The uniform standard of the report is published regularly in “Hong Kong Medicine.”